New Market Research Report: NeuroSigma, Inc. - Product Pipeline Analysis, 2013 Update
NeuroSigma, Inc. (NeuroSigma) is a medical device company. The company develops and commercializes trigeminal nerve stimulation technology for a variety of neurologic and psychiatric disorders. It offers treatments for epilepsy, depression, attention deficit hyperactivity disorder (ADHD), and post-traumatic stress disorder (PTSD). The company concentrates in preclinical research and development, as well as Phase I, II and III clinical trials. NeuroSigma's product pipeline includes eTNS and sTNS. Its trigeminal nerve stimulation is a medical treatment in which mild electrical signals stimulate...
View full press release